Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes. - Wikidata - awgldk - TriplyDB

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.

http://www.wikidata.org/entity/Q35841191

about

Bidirectional Relationships and Disconnects between NAFLD and Features of the Metabolic Syndrome Nutritional modulation of insulin resistance Dietary sodium reduction does not affect circulating glucose concentrations in fasting children or adults: findings from a systematic review and meta-analysis Non-alcoholic fatty liver disease.Effects of resveratrol in experimental and clinical non-alcoholic fatty liver disease Non-alcoholic Fatty Liver Disease Is a Risk Factor for Type 2 Diabetes in Middle-aged Japanese Men and Women.Liver fat: a relevant target for dietary intervention? Summary of a Unilever workshop Nonalcoholic Fatty Liver Disease: Epidemiology, Pathogenesis, Natural History, Diagnosis, and Current Treatment Options.Liver Fat, Hepatic Enzymes, Alkaline Phosphatase and the Risk of Incident Type 2 Diabetes: A Prospective Study of 132,377 Adults Association between the Fatty Liver Index and Risk of Type 2 Diabetes in the EPIC-Potsdam Study.Combined influence of nonalcoholic fatty liver and body size phenotypes on diabetes risk Fatty liver, insulin resistance, and features of metabolic syndrome: relationships with coronary artery calcium in 10,153 people Fatty liver disease: Disparate predictive ability for cardiometabolic risk and all-cause mortality Metabolic crosstalk between choline/1-carbon metabolism and energy homeostasis.Extrahepatic Manifestations of Nonalcoholic Fatty Liver Disease Non-alcoholic fatty liver disease and diabetes.Genetically elevated fetuin-A levels, fasting glucose levels, and risk of type 2 diabetes: the cardiovascular health study Racial/ethnic differences in hepatic steatosis in a population-based cohort of post-menopausal women: the Michigan Study of Women's Health Across the Nation.Association of Urinary Sodium Excretion With Insulin Resistance in Korean Adolescents: Results From the Korea National Health and Nutrition Examination Survey 2009-2010.Serum ferritin is associated with non-alcoholic fatty liver disease and decreased Β-cell function in non-diabetic men and women.Radix Astragali Improves Dysregulated Triglyceride Metabolism and Attenuates Macrophage Infiltration in Adipose Tissue in High-Fat Diet-Induced Obese Male Rats through Activating mTORC1-PPAR γ Signaling Pathway.Dorothy Hodgkin Lecture 2012: non-alcoholic fatty liver disease, insulin resistance and ectopic fat: a new problem in diabetes management.Nonalcoholic fatty liver disease: cause or consequence of type 2 diabetes?Non-alcoholic fatty liver disease predicts type 2 diabetes mellitus, but not prediabetes, in Xi'an, China: a five-year cohort study.Risk of the development of Type 2 diabetes in relation to overall obesity, abdominal obesity and the clustering of metabolic abnormalities in Japanese individuals: does metabolically healthy overweight really exist? The Niigata Wellness Study.The Asia-Pacific Working Party on Nonalcoholic Fatty Liver Disease Guidelines 2017 Part 1: Definition, risk factors and assessment.Fatty Liver, Insulin Resistance, and Obesity: Relationships With Increase in Coronary Artery Calcium Over Time.Nonalcoholic Fatty Liver Disease and Coronary Artery Calcification in a Northern Chinese Population: a Cross Sectional Study.Using Spatial Disease Patterns and Patient-Level Characteristics to Describe Prevalence Elastic Behavior in Treatment for Latent Tuberculosis Infection (LTBI).Low alcohol consumption increases the risk of impaired glucose tolerance in patients with non-alcoholic fatty liver disease.Differences in the risk of fatty liver for onset of impaired fasting glucose according to baseline plasma glucose levels.Prevalence of biopsy-proven non-alcoholic fatty liver disease in severely obese subjects without metabolic syndrome.Long term trends and racial/ethnic disparities in the prevalence of obesity.Muscle cells challenged with saturated fatty acids mount an autonomous inflammatory response that activates macrophages.Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-Aged Adults in the Framingham Study.A Prospective Study of Obesity, Metabolic Health, and Cancer Mortality.Structured lifestyle intervention based on a trans-cultural diabetes-specific nutrition algorithm (tDNA) in individuals with type 2 diabetes: a randomized controlled trial.EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease: is universal screening appropriate?Dietary acid load, insulin sensitivity and risk of type 2 diabetes in community-dwelling older men.Visceral, subcutaneous abdominal adiposity and liver fat content distribution in normal glucose tolerance, impaired fasting glucose and/or impaired glucose tolerance.

P2860

Q26765455-7A65BF9B-A702-4436-813E-D037139F27C5 Q26824738-3D91661C-05AC-467E-8CB6-A7245B211257 Q26863519-96B4AA99-CD4F-4CC8-AEA9-5B563CE7CBA4 Q30430392-2B896E7D-2A92-4CEE-9DBB-74F45C495E24 Q33563877-22EF3C8B-EB47-446D-A1EF-F26F0B0B3654 Q33760722-F1E1A520-DD53-4710-94F8-14B7A78D4C8B Q33791133-BA647C31-6B9E-4781-8492-77184484513C Q33855157-46780666-D80E-4892-9D73-8067CCE0A9E9 Q33875821-E02A6642-78B2-4F9A-B4F7-E0589325A40D Q35527594-10FCD4FF-9178-4828-9AEF-4D439BCCD120 Q36222629-23AF1535-7F29-4D72-9A73-81A484AC254E Q36334667-2F30DB33-18B7-467B-9E64-BD5E2F3B43F8 Q36401621-F31C1ADE-50A9-4380-9147-9AC2097FA746 Q36759438-D8769A99-C593-4C18-930D-3BC12132EC69 Q36921610-9BAFED45-FA1D-4EA8-9C6E-767A86128311 Q37091659-F3208150-B278-444E-B766-36DC23F987B0 Q37193574-807442C9-FB62-4339-80EE-1470703E0A2D Q37204875-3EB21D65-15C8-4C21-9B67-8F4C77F215A4 Q37206387-C7EBB2DA-0E43-48D1-B5DC-0F3EAB2F2EAA Q37619238-37FCFE51-5A85-493C-A7C7-101B80895892 Q37725568-952006BD-4FA6-4B1B-994D-67E635FFC25B Q38016566-9CA1222E-E054-4FFC-8D75-B252FA974272 Q38859044-88975F53-0623-4C31-BF51-2AA1AE57BE64 Q39017557-1F7E8220-0C39-4854-88E4-DE41636FC8C8 Q39091977-6BAE9C21-4370-401E-A6A4-A30853051B12 Q39410610-47B504A8-070F-4BD7-BE6F-91C324EFE9C4 Q39903509-32F8FCFA-DDE3-4D52-B688-B665B253A4AF Q40064196-99EB8B8E-7072-4303-B82E-C72D6645DC28 Q40255221-CB889BB8-CC79-4696-AB93-B10129A110CA Q40513962-12475DD4-C027-483D-9473-9815C473E6B7 Q40683053-997983CC-F82E-4344-8095-8E6EB0FE5E4E Q40922307-9F3C238D-79F0-4193-A551-47A05445BCB0 Q42220140-1AA9589A-53D2-4D62-85CA-8B1D892869D7 Q42359004-18D3E8B0-53DF-41C5-8BDB-E37388932926 Q46030301-A5EA864B-0DD9-474A-8254-8BD4DFD925B6 Q48231385-4717D977-E8B5-4335-A73A-4B7960D48F48 Q49518887-456B9427-F527-4D90-A847-9648CD42B848 Q50672788-110621A1-AC1A-408D-AA0C-AD6AEF6B9286 Q51082928-49355F20-7373-4AC6-BCBE-EC17B5785181 Q51316416-0F875713-9315-4C01-9848-66848C94CE9D

P2860

Combined influence of insulin resistance, overweight/obesity, and fatty liver as risk factors for type 2 diabetes.

http://www.wikidata.org/entity/Q35841191

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年論文

@yue

2012年論文

@zh-hant

2012年論文

@zh-hk

2012年論文

@zh-mo

2012年論文

@zh-tw

2012年论文

@wuu

2012年论文

@zh

2012年论文

@zh-cn

name

Combined influence of insulin ...... k factors for type 2 diabetes.

@ast

Combined influence of insulin ...... k factors for type 2 diabetes.

@en

type

label

Combined influence of insulin ...... k factors for type 2 diabetes.

@ast

Combined influence of insulin ...... k factors for type 2 diabetes.

@en

prefLabel

Combined influence of insulin ...... k factors for type 2 diabetes.

@ast

Combined influence of insulin ...... k factors for type 2 diabetes.

@en

P1433

Q35841191-766DF620-154F-429A-9248-818DE7F19A8E

P1476

Q35841191-AA317813-3CFC-437B-A7EF-94A1EA6619ED

P2093

Q35841191-46C59632-C481-44FE-960E-F0E13EB2C6B4

Q35841191-CFD3096B-5B06-405B-B5F6-BDAEB5DF63C3

Q35841191-FF2C1A5F-691A-45BF-B4B2-9055C2ADC8BA

P2860

Q35841191-044C0166-F95A-47BC-8CDE-43E553784356

Q35841191-0D5BB8E9-37F1-4FB2-A671-E7214C5CD924

Q35841191-16D66D42-5E0C-4FAD-9E36-5958467C388A

Q35841191-17A7DB80-9A05-444F-B89F-4CF3BF54E25F

Q35841191-194B44F0-615B-41EC-86AD-39897A7DAE2B

Q35841191-1EBC324C-A98D-4F85-82AB-50A959D3F476

Q35841191-20C52BFB-ADDD-48EF-940C-4AE471EE1A48

Q35841191-2A6FE81D-614A-4E01-82E0-D895692910B2

Q35841191-2AD487B1-965E-430C-A2A0-5234E74A2D73

Q35841191-351EA4FD-47CB-471D-A0F7-E3A2AF7CF98E

P304

Q35841191-4C783E3D-E269-4A63-8E3F-F7CB78ED8B84

P31

Q35841191-D725D206-1CB0-47D2-935F-904A3DA313CD

P356

Q35841191-7C159A27-E39B-49E4-97A3-CDF8E05C69A8

P407

Q35841191-14609388-0A87-4C7F-BBFB-9DC2C2AAA88E

P433

Q35841191-CDD26A5D-FCA3-42B2-A931-78786EE69162

P478

Q35841191-0EAC1E15-6444-4C4C-BD5E-F6EC3D46D090

P50

Q35841191-DDDA7E59-3A1C-4870-BBB1-A4524E4304CE

P577

Q35841191-64BB7E26-4378-423B-8EB4-F88DEDBF2331

P5875

Q35841191-42E9F92C-EA55-4477-9D6D-E4206F9F865B

P698

Q35841191-96A1BEA2-C457-4D3B-956A-D3202A6D0468

P921

Q35841191-5EA9725E-042B-4A36-B535-C8F349122BDC

Q35841191-787EC221-1FCA-42BE-BF1D-99650E1FE9DC

P932

Q35841191-878F93A3-4B31-4730-90F1-37FEDF6D285E

P356

P1433

P1476

Combined influence of insulin ...... k factors for type 2 diabetes.

@en

P2093

Ki-Chul Sung

http://www.w3.org/2001/XMLSchema#string

Sarah H Wild

http://www.w3.org/2001/XMLSchema#string

Woo-Shin Jeong

http://www.w3.org/2001/XMLSchema#string

P2860

Global prevalence of diabetes: estimates for the year 2000 and projections for 2030

Mechanisms linking obesity to insulin resistance and type 2 diabetes

Long-term follow-up of patients with NAFLD and elevated liver enzymes

Ultrasound scanning in the detection of hepatic fibrosis and steatosis

Randomized controlled trial testing the effects of weight loss on nonalcoholic steatohepatitis.

Nine-year incident diabetes is predicted by fatty liver indices: the French D.E.S.I.R. study

Dissociation between intrahepatic triglyceride content and insulin resistance in familial hypobetalipoproteinemia.

Interrelationship between fatty liver and insulin resistance in the development of type 2 diabetes

Sirtuin 1 (SIRT1) protein degradation in response to persistent c-Jun N-terminal kinase 1 (JNK1) activation contributes to hepatic steatosis in obesity.

Resistance exercise reduces liver fat and its mediators in non-alcoholic fatty liver disease independent of weight loss

P304

717-722

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.2337/DC11-1853

http://www.w3.org/2001/XMLSchema#string

P407

P433

4

http://www.w3.org/2001/XMLSchema#string

P478

35

http://www.w3.org/2001/XMLSchema#string

P50

Christopher D Byrne

P577

2012-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

221835827

http://www.w3.org/2001/XMLSchema#string

P698

22338098

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3308286

http://www.w3.org/2001/XMLSchema#string